My outgoing, active daughter is now dying before my eyes after mistaking fatal heart condition for bloating
GUT WRENCHING My outgoing, active daughter is now dying before my eyes after mistaking fatal heart condition for bloating
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
CHARLOTTE Kent is "starving to death" in front of her parents after a fatal heart condition was tragically mistaken for bloating.
The 25-year-old is now bedridden and unable to eat after a five-year-long 'fight' with a rare vascular disorder that's slowly killing her.
5
Charlotte Kent before she became ill
Credit: SWNS
5
The 25-year-old relies on a nasogastric tube to survive
Credit: SWNS
5
The once outgoing youngster with a distended stomach
Credit: SWNS
Charlotte, once a "lively" and "outgoing" student with dreams of becoming a police officer, has been diagnosed with superior mesenteric artery (SMA) syndrome, a devastating condition where one of her major arteries is crushing her intestine.
She first believed her symptoms were down to bloating from excessive gym training, but they gradually worsened over time, leaving her unable to keep food down and dangerously underweight.
Now, her mum Leanne Bennett, 46, said she is 'watching her [daughter] slowly die' and is desperately fundraising for a life-saving operation in the US.
Charlotte, from Earith, Cambridgeshire, has suffered multiple bowel obstructions, constant vomiting, and now relies on a nasogastric (NG) tube to survive.
Read more on digestion
BACKSIDE STORY Gross but simple test reveals how fast your gut works and explains bloating
She's been in and out of hospital since her early twenties, spending a staggering 47 out of the last 60 months in a hospital bed.
Her condition is so rare that UK doctors failed to recognise it for years, and she was only diagnosed after her mum sought the help of a private radiologist.
Leanne said: 'Charlotte is dying before my eyes, her body is just slowing down.
'Because SMA is so rare, doctors in the UK have little understanding about it – and she hasn't been offered the new surgery to correct it.
'The Alvear procedure is so new, it isn't yet available on the NHS.
'To be honest, she's been presenting with symptoms, like a distended stomach, from a fairly young age, but I always put it down to growth spurts.'
I'm plagued my 'no-burp syndrome' - I get so bloated I look five months pregnant
Charlotte was a sporty teen who began gymnastics at 13, and Leanne said she was constantly on the go, never one to sit still.
But even then, she often complained of feeling sick and bloated, which her family chalked up to childhood bugs or hormonal changes.
It wasn't until she was 20 that the symptoms suddenly took a darker turn, with Charlotte experiencing a mysterious pain on her right side.
'In February 2020, doctors whipped her appendix out in the hope it would stop her pain,' Leanne said.
'But it only got worse."
She added: 'We started taking her to hospital every other month, because it was always something, pain, massive stomach distension, being sick and, eventually, malnutrition.
5
She's been in and out of hospital since her early twenties
Credit: SWNS
5
Charlotte is now bedridden
Credit: SWNS
'In the last 60 months, she has spent 47 of them in a hospital bed.'
Despite dozens of tests, Charlotte's care team couldn't pinpoint what was wrong, but confirmed she was dangerously malnourished.
By 2021, she was fitted with a nasogastric (NG) tube to keep her alive, and her family feared the worst.
Refusing to give up, Leanne paid to see a private radiologist, who finally confirmed Charlotte had SMA syndrome, a condition that affects only 0.3 per cent of people in the US and an unknown number in the UK.
I wouldn't wish this on anybody, I just want a normal life - and I don't think that's asking much
Chalotte Kent
He told them the only way to save her would be a cutting-edge op called the Alvear procedure, which untwists and repositions the duodenum.
The surgery isn't yet offered on the NHS and can cost upwards of £30,000 privately in the US.
Leanne said: 'It's such a short procedure, it only takes one-to-two hours, if everything goes well – and it could save Charlotte's life.
'It's her only hope.'
What is superior mesenteric artery (SMA) syndrome?
SMA syndrome is a rare digestive condition where part of your small intestine, called the duodenum, gets crushed between two major arteries in your belly: the abdominal aorta and the superior mesenteric artery.
This crushing effect causes a blockage, making it difficult or impossible for food to pass through the gut.
Over time, this can lead to severe malnutrition, vomiting, and weight loss, and in some cases, can be life-threatening.
SMA syndrome is more likely to affect people who have lost weight rapidly or have very little fat cushioning between their organs.
Symptoms you might notice include: Feeling full very quickly after eating
Constant bloating or a distended stomach
Nausea and vomiting
Severe abdominal pain
Difficulty keeping food down
Ongoing weight loss
Source: Cleveland Clinic, NHS, National Library of Medicine
She's now racing to find a UK-based surgeon who could offer the same treatment, to spare Charlotte the risks of travelling in her fragile state.
Meanwhile, Charlotte says she feels stuck while the rest of the world moves on.
She said: 'I have been struggling for way too long with the illness.
'It's really hard to deal with day-to-day.
'I feel like my life has stopped, the world continues to go round and I'm stuck in the same place.
"I wouldn't wish this on anybody, I just want a normal life - and I don't think that's asking much."
Leanne has launched a GoFundMe fundraiser to help cover treatment costs and give her daughter a second chance at life.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
17 minutes ago
- The Independent
Cancer patients to receive ‘game-changing' vaccine in new NHS trial
Patients in England with head and neck cancer will be fast-tracked onto a clinical trial for a "potentially transformative" new vaccine, under an initiative announced by the NHS. The first patients have received the jab, which uses mRNA technology to train the immune system to fight cancerous cells, with more set to be enrolled at their nearest NHS hospital. Head and neck cancer is a general term to describe forms of the disease in those regions of the body, and can include cancer of the mouth, throat or voice box. Around 11,000 new cases are diagnosed in England every year. Aggressive forms are difficult to treat, with high rates of recurrence and two-year survival rates under 50 per cent. The vaccine used in the study has been designed to create two proteins that are commonly found in head and neck cancers associated with high-risk types of human papillomavirus (HPV). These types of cancer, known as squamous cell cancers, develop from flat, scale-like cells in the outer layer of the skin and other areas of the body. More than 100 patients with advanced forms of the disease will be matched to the trial, known as AHEAD-MERIT (BNT113), which will run at 15 hospitals over the next year. Health minister Karin Smyth described the plan as a 'massive win for cancer patients'. 'These cancer vaccines could be game-changing for patients facing some of the most challenging diagnoses. By getting these trials running in our NHS, we're putting ourselves at the forefront of medical innovation, improving outcomes for people living with cancer.' NHS England has joined forces with life sciences company BioNTech to help identify potentially eligible patients to refer to NHS hospitals running the trial. The trial is the third to be run through the NHS Cancer Vaccine Launch Pad, which is supported by the Cancer Research UK -funded Southampton Clinical Trials Unit. Professor Peter Johnson, national clinical director for cancer at NHS England, said: 'It's fantastic that more patients with advanced head and neck cancers will now be able to access this potentially transformative vaccine, offering renewed hope of holding the disease at bay.' Tamara Kahn, chief executive at Oracle Head & Neck Cancer UK, said the trial 'offers crucial hope to those living with advanced stages of cancer'. 'While we advocate for HPV vaccination to prevent these cancers, those already fighting this devastating disease urgently need new treatments that could mean more time with loved ones,' she added. Chris Curtis was diagnosed with HPV-related head and neck cancer in 2011 and set up a support charity, The Swallows. The 67-year-old, from Blackpool, said: 'As a survivor of HPV-related head and neck cancer, I know first-hand the physical, emotional, and psychological toll this disease takes not just on the patient, but on the entire support system around them. 'With this aggressive cancer, you live in the fear of reoccurrence every day – so anything that could help control the disease or give people peace of mind is groundbreaking – it'll allow people to get on with their lives and move forward.' The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer about 550 patients to trials for vaccines for bowel and skin cancers. Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: 'The Cancer Vaccines Launch Pad is an important route to fast-track promising mRNA vaccine technology into clinical trials. 'Research into personalised cancer treatments is vital. There are over 200 different types of cancer and it's unlikely there will ever be a single cure that works for everyone. 'That's why it's vital that we support a wide range of research, so that more people can live longer, better lives, free from the fear of cancer.'
Daily Mail
18 minutes ago
- Daily Mail
Huge cancer boost as hundreds of patients are set to be offered jab that can protect against the disease
Hundreds of head and neck cancer patients will be given fast-track access to a new 'transformative' cancer jab. The injection targets the advanced form of the disease—which experts believe will herald a new era in fighting the cancer. It works by boosting the immune system's response, helping it to 'attack' cancer cells containing human papillomavirus (HPV) proteins. Research has long suggested that HPV may be responsible for up to 70 per cent of head and neck cancers. The move also marks an expansion of NHS England's cancer vaccine launch pad programme, which has already allowed over 500 patients to receive bowel and skin cancer vaccines within the last year. It is estimated more than 100 patients with advanced head and neck cancer will benefit from the jab via the AHEAD-MERIT (BNT113) trial, which will run at 15 hospitals over the next year. Experts today said the 'game-changing' jab offered 'renewed hope of holding the disease at bay'. Head and neck cancer is an umbrella term for cancers of the mouth, throat, voice box, nose, sinuses and salivary glands. HPV is a common virus spread through close contact, including sex, and is usually harmless. However, in some cases—for reasons not fully understood—it can trigger cancerous changes in healthy tissue. Despite advances in care for patients with head and neck cancer, the advanced form of the disease is difficult to treat and has high rates of recurrence, with two-year survival rates at under 50 per cent. The vaccine is designed to create two proteins that are commonly found in head and neck cancers associated with high-risk types of HPV. NHS England has joined forces with life sciences company BioNTech to help identify potentially eligible patients to refer to NHS hospitals running the trial. Health minister Karin Smyth described the plan as a 'massive win for cancer patients'. She added: 'These cancer vaccines could be game-changing for patients facing some of the most challenging diagnoses. 'By getting these trials running in our NHS, we're putting ourselves at the forefront of medical innovation, improving outcomes for people living with cancer.' Professor Peter Johnson, national clinical director for cancer at NHS England, also said: 'It's fantastic that more patients with advanced head and neck cancers will now be able to access this potentially transformative vaccine, offering renewed hope of holding the disease at bay.' Chris Curtis was diagnosed with HPV-related head and neck cancer in 2011 and set up a support charity, The Swallows. The 67-year-old, from Blackpool, said: 'As a survivor of HPV-related head and neck cancer, I know first-hand the physical, emotional, and psychological toll this disease takes not just on the patient, but on the entire support system around them. 'With this aggressive cancer you live in the fear of reoccurrence every day—so anything that could help control the disease or give people peace of mind is groundbreaking—it'll allow people to get on with their lives and move forward.' Cancers that affect the head and neck are the eighth most common form of cancer overall in the UK, although they are two to three times more common in men than in women. About 12,500 new cases are diagnosed each year, according to Cancer Research UK, and incidences are on the rise. Around eight in 10 people will get HPV at some point in their life and their body will clear it without any problems, according to the NHS. Experts have repeatedly urged people to get the HPV vaccine to reduce their risk of HPV cancers. Yet, according to the World Health Organisation (WHO), the UK's HPV vaccine uptake lags shockingly behind other countries — just 56 per cent among girls and 50 per cent for boys. Denmark, by comparison, records a rate of around 80 per cent. In the UK, the jab was offered to all girls in school year 8 since September 2008. But eligibility was only expanded to boys in year 8 from September 2019.
BBC News
18 minutes ago
- BBC News
Why a dockside health clinic could be the future of NHS care
Tom Parker was working alone three miles (4.8km) off the Devon coast when his fishing boat hit a wave and lurched to one side."I was pulling one of the ropes and I slipped and fell," he says. "I had this really, really bad pain in my ankle. So much so, I couldn't get up off the floor."He didn't know it at the time, but Tom, 37, had broken his fibula and badly damaged his ankle somehow hauled in his fishing gear and made it to hospital to get patched up, but months after the accident his wound just wouldn't heal was only after he turned up at an innovative clinic on the quayside in Brixham that he was put on strong antibiotics and told he needed a second operation."Without that service, I would have probably ended up with my leg turning septic and I'm not too sure what would have happened after that," he a 10-year plan, published last month, health officials said the NHS in England needed to undergo a radical shift, away from hospitals to community care, and away from treating sickness to preventing it in the first are already small-scale examples of that approach in action across the country. So what can we learn from the Brixham model and how can the idea of targeted, local care be extended to treat millions more NHS patients? On a clear summer morning a spare room in the trawler agent's offices in Brixham harbour is quickly being converted into a temporary health screens are dragged across to split up the space: a makeshift reception at the front and then just enough room to cram in two GPs, a pharmacist, a physiotherapist, two nurses and someone organising prostate cancer a steady line of port workers coming in, from buyers in the fish market next door to crews from the trawlers in the harbour."The skippers of the boats and the whole fishing community now know exactly where to find us," says Dr James Gunning, the local NHS GP in charge of the clinic that day."They're a community that fits into health inequalities, where a population either can't access, or struggles to access, normal NHS services."Clinic staff start early in the morning, walking around the docks and coaxing workers off the boats with promises of free health screenings and physio."Fishermen don't have nine-to-five jobs, they don't have lunchtime where they can just pop off their fishing boat and to the GP's office, and so it's really important that we take those services to them," says Sandra Welch, chief executive of the Seafarers Hospital Society, which runs the initiative along with another charity, the Fishermen's Mission.A pop-up Seafit clinic operates every three months in Brixham and at similar sites at ports across the UK, including Folkestone, Peterhead and Kirkeel in Northern services have started to expand and now offer skin cancer checks, mobile dental services and access to mental health counselling. In its 10-year plan the NHS accepts that those who live in coastal and rural areas are more likely to experience worse health outcomes and to die younger. Seaside and coastal towns often have older populations with more complex health needs, while at the same time local NHS services can suffer from recruitment problems, leaving staffing gaps where they are needed analysis of hospital statistics by the BBC suggests NHS trusts in England treating coastal communities tend to have higher than average wait times for both emergency care and appointments booked in advance, like surgery. The answer, according to NHS bosses and the Westminster government, is to shift as much treatment as possible out of those expensive the 10-year plan a network of 300 neighbourhood health centres will be opened across England, starting in areas with the lowest healthy life expectancy. The sites, which should eventually be open 12 hours a day, six days a week, will be staffed by a mix of GPs, nurses, social care workers, pharmacists, mental health specialists and other big idea, as with the Brixham fishermen's clinic, is to better tailor health services to local communities, and offer people more checks and tests to stop them falling sick in the first of this might feel very ambitions were set out by ministers in 2019, 2015 and even by the Blair government back in the early 2000s."Despite being the right aim, none of those truly delivered," says Luisa Pettigrew, a GP and senior policy fellow at the Health Foundation think tank."Moving money out of hospitals and into community services is hard to do. You need the upfront investment and the results might not be visible for five or 10 years, in some cases longer."Healthcare unions have also questioned how the new centres will be staffed, saying doctors "must not be moved around like pieces on a chess board or made to work even harder". The medics working in Brixham though are convinced their local, preventative approach can benefit not just the fishing community but the wider health service. "We've managed to find new diabetic patients who otherwise may have gone on to develop more serious disease," says Dr Gunning. "We've picked out others with cardiovascular disease, and those with high blood pressure. So we would certainly hope we can prevent more costly illness from developing."Rob Caunter, who finally retired from the fish market this year, is just finishing his radium treatment for prostate cancer. The 66-year-old, who has a family history of the disease, was diagnosed after staff at the clinic convinced him to take a blood test."I was gobsmacked really because I didn't think there was anything wrong with me," he says. "If I never went for the checks, I don't think I would be here today. So it was a real godsend for them to come down to the quay."
